Fine-needle cytology of cutaneous juvenile xanthogranuloma and langerhans cell histiocytosis
β Scribed by Ambrogio Fassina; Andrea Olivotto; Rocco Cappellesso; Roberto Vendraminelli; Matteo Fassan
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2010
- Tongue
- English
- Weight
- 746 KB
- Volume
- 119
- Category
- Article
- ISSN
- 1934-662X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND:
In pediatric patients, a cutaneous nodule is usually diagnosed by performing an excisional biopsy, but fineβneedle cytology (FNC) is a safer and noninvasive diagnostic method widely used to obtain diagnostic specimens with little stress to the patient. The authors compared the ability of FNC and biopsy to differentiate Langerhans cell histiocytosis (LCH) from juvenile xanthogranuloma (JXG).
METHODS:
Correlating cytological results with histological findings, the authors reviewed 27 patients (15 males and 12 females; mean age, 37 months; range, 1 month to 14 years) admitted to the University of Padua Department of Pediatrics from 1998 to 2010.
RESULTS:
Cytology smears were adequate in all 27 (100%) patients: 14 (52%) were classified as having JXG, 12 (44%) as having LCH, and 1 (4%) as having a doubtful finding. A biopsy was also performed in 20 of these patients, and in all but 1, the 2 methods were completely concordant.
CONCLUSIONS:
FNC is safe and useful in the diagnostic workup of pediatric patients with cutaneous nodules and has no contraindications to its use as the initial diagnostic procedure. Cancer (Cancer Cytopathol) 2011;. Β© 2010 American Cancer Society.
π SIMILAR VOLUMES
Rosai-Dorfman disease (RDD; sinus histiocytosis with massive lymphadenopathy) and Langerhans cell histiocytosis (LCH) are two different yet pathogenetically related histiocytic disorders. While systemic and localized forms have been identified in both diseases, each has its own characteristic histol